Increasing cefazolin use for surgical prophylaxis in penicillin-allergy-labeled patients.

Antimicrob Steward Healthc Epidemiol

Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.

Published: January 2023

Objective: Penicillin (PCN) allergy labels affect antimicrobial selection for surgical prophylaxis. We aimed to increase the percentage of cefazolin usage in patients with PCN allergy labels undergoing orthopedic surgery from 50% to 80%.

Design: Quality improvement initiative.

Setting: Children's Mercy Kansas City (CMKC), a freestanding children's hospital.

Patients: Children scheduled for an orthopedic surgery (excluding spinal surgery) at CMKC who had a PCN allergy label and received a perioperative antibiotic.

Methods: No standardized process existed to identify and clarify PCN-allergic-labeled patients preoperatively. We developed a process for patient identification combined with a pharmacist phone interview for PCN allergy clarification. In plan-do-study-act (PDSA) part 1, we implemented a computer-generated patient list. In PDSA part 2, we combined automated identification with a phone interview. In PDSA part 3, we enhanced the patient list, making it timely and concise. In PDSA part 4, we included a PCN allergy clarification electronic survey to caregivers via the electronic medical record.

Results: Cefazolin use in PCN-allergic surgical patients increased from 50% to 74% following interventions. Patients who had their PCN allergy label clarified were 4 times more likely to receive cefazolin compared to those whose allergy labels were not clarified (OR, 4.21; 95% CI, 1.68-11.61; = 0.003). Moreover, 90% of patients received cefazolin when their PCN allergy was clarified and cefazolin was recommended. When a PCN allergy label was not clarified, only 59% of patients received cefazolin.

Conclusions: Appropriate clarification and documentation of PCN allergy labels increases the use of cefazolin for surgical prophylaxis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879898PMC
http://dx.doi.org/10.1017/ash.2022.360DOI Listing

Publication Analysis

Top Keywords

pcn allergy
36
allergy labels
16
surgical prophylaxis
12
allergy label
12
allergy
10
pcn
9
cefazolin surgical
8
patients pcn
8
orthopedic surgery
8
phone interview
8

Similar Publications

Objective: To explore the progress that the Veterans Health Administration has made to minimize the impact of the penicillin (PCN) allergy label, we determined the proportion of Veterans who reported a PCN-class allergy at the time of hospitalization and described antibiotic use in hospitalizations with and without a PCN-class allergy.

Design: Cross-sectional study.

Participants: National sample of 6,541,299 acute care admissions between 2011 and 2022.

View Article and Find Full Text PDF

Is the Anamnesis Enough to De-Label Patients with Reported Beta-Lactam Allergy?

J Clin Med

November 2024

Department of Internal Medicine, Allergology and Clinical Immunology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-752 Katowice, Poland.

The decision whether to de-label patient with suspected BL hypersensitivity is based on risk stratification. The aim of this study was to prepare a characteristic of diagnostic risk groups and to create a model enabling the identification of the low-risk diagnostic group. We analyzed the medical records of patients hospitalized due to suspected hypersensitivity to BL antibiotics.

View Article and Find Full Text PDF

A penicillin allergy stewardship team to address unconfirmed pediatric penicillin allergies in Houston, Texas.

Ann Allergy Asthma Immunol

December 2024

Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas; Division of Immunology, Allergy, and Retrovirology, Texas Children's Hospital, Houston, Texas; Department of Pediatrics, Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, Texas.

Background: Penicillin (PCN) allergy labels are the most common drug allergy label and limit use of first-line antibiotics for many pediatric bacterial infections. Improving access to PCN allergy evaluations is a priority for allergy and immunology (A&I) and infectious diseases (ID) programs.

Objective: To increase the number of completed PCN allergy evaluations from 6 to 24 per month from January 2022 to December 2023.

View Article and Find Full Text PDF

Are Cellular Bone Matrix Allografts a Viable Option for Mandibular Tissue Engineering and Reconstruction?

J Oral Maxillofac Surg

September 2024

Professor and Chairman, Department of Oral and Maxillofacial Surgery, University of Louisville, Louisville, KY.

Background: Traditional mandibular reconstruction has relied on the use of vascularized and non-vascularized autografts. The use of allografts and tissue engineering modalities has risen as an alternative.

Purpose: The purpose of this study was to determine the success of a cellular bone matrix (CBM) allograft composed of lineage committed bone forming cells for mandibular tissue engineering and reconstruction.

View Article and Find Full Text PDF

Penicillin (PCN) allergy delabeling is an important component of antimicrobial stewardship; however, widespread implementation has lagged. We found that most patients had low-risk PCN allergy histories eligible for delabeling without skin testing. Pharmacist-led risk stratification and drug challenge expanded access to delabeling independently from an Allergy/Immunology service.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!